Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acadia Healthcare (DE:7RA)
FRANKFURT:7RA
Holding DE:7RA?
Track your performance easily
7RA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€49.20 - €80.50
Previous Close€52.5
Volume0.00
Average Volume (3M)1.00
Market Cap
€5.07B
Enterprise Value€6.90B
Total Cash (Recent Filing)$77.17M
Total Debt (Recent Filing)$1.97B
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Oct 30, 2024EPS Estimate
€0.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding92,867,210
10 Day Avg. Volume0
30 Day Avg. Volume1
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.71
Price to Sales (P/S)1.80
Price to Cash Flow (P/CF)8.10
P/FCF Ratio35.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.26
Enterprise Value/Gross Profit2.44
Enterprise Value/Ebitda28.81
Forecast
1Y Price Target
€77.26Price Target Upside47.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Acadia Healthcare News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceACHC reported EBITDA of $187.6m on $796m of revenue, beating consensus estimates by 130bps and 140bps, respectively.
Growth ProspectsFading controversies, solid execution, and clear evidence that the growth arch is tilted decidedly higher should push both estimates and the forward valuation higher.
Regulatory DevelopmentsThe DOJ did not impose a new Corporate Integrity Agreement when it finalized the new settlement, suggesting that the DOJ found little that's material or troubling.
Bears Say
Financial PerformanceACHC narrowed EBITDA guidance while maintaining the midpoint and took down revenue guidance down $25m at the high end, which reflects two facility closures that were break-even EBITDA.
Legal ChallengesThe company received a voluntary request for information from the US Attorney's Office and a grand jury subpoena, which could imply potential legal challenges.
Regulatory And Legal OverhangThe regulatory and legal overhangs from the 130+ page Senate Finance Committee report and further lawsuit fears will limit upside going forward as there is really no way to disprove this bear thesis over the near to medium term.
---
Options Prices
Currently, No data available
---
Ownership Overview
2.11% Insiders
37.96% Mutual Funds
0.05% Other Institutional Investors
38.35% Public Companies and
Individual Investors
7RA FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was €49.20 and its highest was €80.50 in the past 12 months.
What is Acadia Healthcare’s market cap?
Currently, no data Available
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Oct 30, 2024 which is in 11 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 31, 2024. The company reported €0.831 earnings per share for the quarter, beating the consensus estimate of €0.8 by €0.031.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is €0.82.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 92,867,210 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of €0.831 in its last earnings report, beating expectations of €0.8. Following the earnings report the stock price went down -4.032%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Among the largest hedge funds holding Acadia Healthcare’s share is Viking Global Investors LP. It holds Acadia Healthcare’s shares valued at 219M.
---
Acadia Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€77.26 (47.16% Upside)
€77.26 (47.16% Upside)
Blogger Sentiment
Bullish
DE:7RA Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.85%
12-Months-Change
Fundamentals
Return on Equity
-0.17%
Trailing 12-Months
Asset Growth
10.25%
Trailing 12-Months
Company Description
Acadia Healthcare
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.
---
7RA Earnings Call
Q2 2024
0:00 / 0:00
---
7RA Stock 12 Month Forecast
Average Price Target
€77.26
▲(47.16% Upside)
Technical Analysis
Acadia Healthcare
―
Universal Health
―
HCA Healthcare
―
Tenet Healthcare
―
Community Health
―
Best Analysts Covering 7RA
1 Year
1 Year Success Rate
11/36 ratings generated profit
1 Year Average Return
-0.08%
assigned a buy rating 23 days ago
Copying Brian Tanquilut's trades and holding each position for 1 Year would result in 30.56% of your transactions generating a profit, with an average return of -0.08% per trade.
---